In conclusion, adult female CCSs carrying the CYP3A4*3 allele appear to have a five-fold lower ovarian function after treatment for childhood cancer, and CYP2B6*2 may have a protective effect on AMH levels in patients receiving CED scores of 8000mg/m2 or more. The gene discussed is AMH; the disease is childhood malignant neoplasm.